Thermo Fisher Scientific Inc.

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a global leader in serving science, providing innovative solutions, products, and services to accelerate scientific research and improve outcomes in various fields such as life sciences, clinical diagnostics, and industrial applications.

Products & Services

Antibodies:Products for detecting and analyzing proteins in research and diagnostics.

Cell Culture Media:Solutions for growing and maintaining cells in laboratory settings.

Chemicals:Reagents and compounds for scientific and industrial use.

Chromatography Columns and Cartridges:Tools for separating and analyzing chemical mixtures.

Lab Equipment:Instruments and devices for laboratory research and experimentation.

Lab Plasticware and Supplies:Consumables and materials for laboratory operations.

Microplates:Plates used for high-throughput screening and assays.

Oligos, Primers, Probes and Genes:Custom DNA/RNA synthesis for molecular biology applications.

TaqMan Real-Time PCR Assays:Tools for precise gene expression and genotyping analysis.

Greener Products:Sustainable and environmentally friendly laboratory products.

Specialties

Life Sciences Bioprocessing Cell and Gene Therapy Clinical Diagnostics Molecular Testing Spectroscopy and Elemental Analysis Digital Solutions for Labs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 2310000000 MR: - FA: €2.1 billion FAN: 2310000000	D: 2025-11-24 FD: 2025-11-24	4 investors
2	RT: Debt T: - FT: Debt	A: 2500000000 MR: - FA: $2.5 billion FAN: 2500000000	D: 2025-09-30 FD: 2025-09-30	4 investors
3	RT: Debt T: - FT: Debt	A: 2500000000 MR: - FA: 2.5 billion FAN: 2500000000	D: 2023-11-28 FD: 2023-11-28	4 investors
4	RT: Unknown T: - FT: Unknown	A: 87400000000 MR: - FA: US$ 87.4 Bn FAN: 87400000000	D: 2023-10-10 FD: 2023-10-10	-
5	RT: Debt T: - FT: Debt	A: 2950000000 MR: - FA: $2.95 billion FAN: 2950000000	D: 2023-08-07 FD: 2023-08-07	4 investors

Debt Latest

2025-11-24

$2.3B

4 investors (Pro only)

Debt 2025-09-30

$2.5B

Debt 2023-11-28

$2.5B

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Shanya Gill

Young Inventor

C

Colin Barton

Retired Dentist and Patient Advocate

Recent News